MEDNAX Revenue and Income Rose After 3Q15 Results

MEDNAX’s YTD price movement was a mix of rises and falls in 2015. After the earnings report, MEDNAX fell 3.4% to close at $71.3 per share as of October 29, 2015.

Gabriel Kane - Author
By

Dec. 4 2020, Updated 10:53 a.m. ET

uploads///md pm

MEDNAX and price movement

MEDNAX (MD) has a market cap of ~$6.7 billion. MEDNAX’s YTD (year-to-date) price movement was a mix of rises and falls in 2015. After the earnings report, MEDNAX fell 3.4% to close at $71.3 per share as of October 29, 2015. The price movement on a weekly, monthly, and YTD basis was -5.4%, -7.2% and 7.8%, respectively.

Article continues below advertisement
Article continues below advertisement

Trading below moving averages

Technically, the price sometimes broke the support of 20-day and 50-day moving averages in 2015. Currently, it’s trading at -8.7% below the 20-day moving average, -10.9% below the 50-day moving average, and -4.9% below the 200-day moving average.

The PowerShares DWA Healthcare Momentum ETF (PTH) invests 3.9% of its holdings in MEDNAX. The ETF tracks an index of US healthcare firms selected and weighted by price momentum. The YTD price movement of the ETF was 3.7% as of October 28, 2015.

The competitors of MEDNAX (MD) and their market caps are:

  • Envision Healthcare Holdings (EVHC), at $5.2 billion
  • Team Health Holdings (TMH), at $4.3 billion
  • Tenet Healthcare (THC), $3.2 billion
  • Community Health Systems (CYH), at $3.4 billion

Performance of MEDNAX in 3Q15

The company reported a net revenue of $722.3 million in 3Q15, a rise of 6.8% when compared to the net revenue of $676.6 million in 2Q15. The operating income rose by 0.43% in 3Q15 on a quarterly basis. The net income and EPS (earnings per share) rose to $90.6 million and $0.97 per share in 3Q15, respectively, a respective rise of 7.84% and 7.77% as compared to the net income of $84.0 million and $0.90 per share in 2Q15.

Meanwhile, cash and cash equivalents fell by 6.7%, and accounts receivables rose by 6.9% in 3Q15. The debt-to-equity ratio rose to 0.94 in 3Q15 as compared to the debt-to-equity ratio of 0.92 in 2Q15.

The company also announced the acquisition of Manassas Anesthesia Associates, Lakeshore Anesthesia Services, Millennium Anesthesia Care, Alegis Revenue Group, and New Jersey Anesthesia Associates (NJAA).

About MEDNAX

MEDNAX is a national medical group. It provides neonatal, anesthesia, teleradiology, maternal-fetal, and pediatric physician sub-specialty services.

Advertisement

Latest Team Health Holdings Inc News and Updates

    Opt-out of personalized ads

    © Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.